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Poliovirus Containment: 
An integral part of polio eradication
As the world works to eradicate polio, we must take precautions to minimize the  
risk of eradicated polioviruses being released from the laboratories and facilities  
that retain them. 
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WHY IT MATTERS
Poliovirus can affect the central nervous 
system, resulting in paralysis and death. 
The last case resulting from wild poliovirus 
type 2 occurred in 1999 and the virus was 
formally declared eradicated in 2015. Even 
with its eradication, wild poliovirus type  
2 continues to be used for research  
and development:
• Laboratories use poliovirus to conduct 
important research for cancer treatment  
and other life-saving work
• Manufacturers use live poliovirus to make 
vaccine to prevent new cases of polio 
from occurring around the globe
• Laboratories conduct research for other 
diseases using potentially infectious 
materials, such as stool or respiratory 
samples. These samples may have been 
collected in regions where wild poliovirus 
was circulating or where the live oral 
poliovirus vaccine was in use.
4 Pillars of Poliovirus Containment
Identify: All countries survey their 
laboratories and other facilities to 
identify infectious and potentially 
infectious poliovirus materials
Destroy: All countries request that 
laboratories and facilities destroy all 
unneeded poliovirus materials
Transfer: Laboratories and facilities 
may choose to transfer needed 
poliovirus materials to designated 
poliovirus-essential facilities 
Contain: Countries will designate 
poliovirus-essential facilities for 
continued work with poliovirus type 2. 
These facilities are expected to comply 
with the World Health Organization 
Global Action Plan requirements.
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WHY CDC?
CDC has a long history in the fight against poliovirus 
worldwide. The agency provides technical assistance 
for poliovirus outbreak response, laboratory testing, 
disease surveillance, vaccination campaign planning, 
program monitoring and evaluation, and research. 
This expertise in poliovirus is combined with CDC’s 
expertise in oversight and monitoring of biosafety and 
security in the laboratory to support U.S. and global 
poliovirus containment efforts.
Vaccinating people against 
poliovirus is still important
Oral polio vaccine (OPV) is still used in many countries. 
In April 2016, the world switched from trivalent OPV, 
which included poliovirus types 1, 2, and 3, to bivalent 
OPV, which only includes poliovirus types 1 and 3. 
Countries where polio is endemic in 2018
In the United States, only inactivated poliovirus 
vaccine (IPV) is used, and over 90% of the population 
is vaccinated against poliovirus. IPV still contains 
all three types of poliovirus and one dose is 
recommended in all countries that use bivalent OPV.
Poliovirus containment  
is necessary to ensure 
polio stays eradicated
Poliovirus containment is a key 
objective of the World Health 
Organization’s Global Polio 
Eradication Initiative. Facilities 
designated as “poliovirus-
essential” must follow defined 
poliovirus containment measures  
to minimize the risk that the virus 
could get into the environment  
and cause harm.
At this time, poliovirus 
containment is only focused on 
poliovirus type 2. There are three 
kinds of poliovirus type 2 that 
need to be contained:  
Wild poliovirus type 2:
Although eradicated, samples 
of wild poliovirus type 2 still 
remain in laboratories and 
vaccine manufacturing facilities.
Vaccine-derived poliovirus type 2:
Rarely, the strain of poliovirus 
in the oral vaccine can mutate 
to a form of poliovirus that can 
cause paralysis and circulate 
like wild poliovirus. 
Oral poliovirus vaccine type 2: 
This weakened strain of 
poliovirus does not cause 
disease, and protects 
against infection with wild 
poliovirus, but is no longer 
used for routine immunization 
anywhere in the world.
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